3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
2565
Uterine Cervical Neoplasms
1684
Endometrial Neoplasms
1008
Fallopian Tube Neoplasms
729
Carcinoma, Ovarian Epithelial
680
Breast Neoplasms
673
Neoplasms
436
Carcinoma, Non-Small-Cell Lung
377
Colorectal Neoplasms
370
Pancreatic Neoplasms
302
Stomach Neoplasms
301
Uterine Cervical Dysplasia
273
Prostatic Neoplasms
261
Lung Neoplasms
250
Melanoma
247
Neoplasm Metastasis
214
Peritoneal Neoplasms
197
Carcinoma, Renal Cell
192
Sarcoma
189
Head and Neck Neoplasms
188
Urinary Bladder Neoplasms
187
Esophageal Neoplasms
186
Recurrence
184
Triple Negative Breast Neoplasms
179
Uterine Neoplasms
176
Vulvar Neoplasms
173
Squamous Cell Carcinoma of Head and Neck
166
Colonic Neoplasms
162
Papillomavirus Infections
152
Small Cell Lung Carcinoma
126
Interventions
cetrorelix
1
Triptorelin Pamoate
1
Menotropins
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Gonadotropins
1
Chorionic Gonadotropin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Endometritis
×
Gynecologic
×
Clear all
NCT04071574
2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2
Completed
200 enrolled